Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
3billion, |
RCV002251270 | SCV002521851 | likely pathogenic | Hajdu-Cheney syndrome | 2022-05-22 | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. Frameshift: predicted to result in a loss or disruption of normal protein function through protein truncation. The predicted truncated protein may be shortened by more than 10%. Most of the known pathogenic variants occurs in the same region, the last exon of the gene. Truncated protein is expect to exert persistent Notch intracellular signal (PMID: 21378985). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline. |